Afinitor Clinical Trials
Here are the 6 most popular medical studies for afinitor
mTOR inhibitor
Everolimus + Letrozole for Ovarian Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing if the combination of everolimus (Afinitor®) and letrozole is effective in the treatment of women with either recurrent or persistent epithelial ovarian, fallopian tube, primary peritoneal or endometrial cancer.
Kinase Inhibitor
Vandetanib + Everolimus for Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing the side effects and best dose of two drugs when given together to treat patients with cancer that has spread. The drugs may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Radioactive Drug
Lutetium Lu 177 Dotatate for Bronchial Neuroendocrine Tumors
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial compares lutetium Lu 177 dotatate to the usual treatment, everolimus, for patients with neuroendocrine tumors that have spread to other parts of the body. Lutetium Lu 177 dotatate may be more effective than everolimus and cause less harm to normal cells.
Popular filter options for afinitor trials
Phase 3 Clinical Trials
View 78 phase 3 medical studies.
Selective Estrogen Receptor Degrader (SERD)
Giredestrant + Everolimus for Breast Cancer
Recruiting2 awardsPhase 3
Redlands, California
This trial will compare two cancer treatments to see which is more effective in treating breast cancer that is Advanced or has Metastasized and is estrogen receptor and human epidermal growth factor receptor 2 positive.
Clinical Trials With No Placebo
View 78 medical studies that do not have a placebo group.
Tyrosine Kinase Inhibitor
Combination Therapy with Neratinib and Everolimus, Palbociclib, or Trametinib for Solid Tumors with Specific Genetic Mutations
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing neratinib in combination with everolimus, palbociclib, or trametinib to see if it is effective in treating solid tumors that have progressed despite prior treatment and have spread to other parts of the body.
View More Afinitor Trials
See another 59 many medical studies focused on afinitor.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.